News
Trump team set to destroy $12m worth of HIV drugs and contraceptives that were bought before closing USAID - The life-saving ...
Aid organizations have been in talks about taking control of the contraceptives and HIV prevention medication, but those ...
Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.
Nina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...
It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...
By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...
Exploring caregiver dependence and social determinants of health reveals critical barriers to HIV care for children, ...
In Lesotho, pills to prevent infection can lead to stigmatisation. But access to a more discreet alternative is under threat ...
When Liemiso Leteba received an injection at the start of the year to protect her from the HIV virus, she felt a rare sense of relief.
New HIV research shows that small changes in the virus affect how quickly or slowly it replicates and how easily it can reawaken in the body. These insights bring researchers closer to finding ways to ...
CHARLOTTESVILLE, Va. (WVIR) - A decades old HIV medication could be a game-changer for people losing their vision to diabetes. New research from UVA Health suggests a low-cost oral drug may ...
A preliminary pilot test of the MIK in a Bronx, NY street outreach syringe exchange program found the MIK is feasible and highly acceptable to a population of people who inject drugs. Participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results